<DOC>
	<DOCNO>NCT00754819</DOCNO>
	<brief_summary>The purpose study evaluate effect colchicine high sensitivity C-reactive protein ( hs-CRP ) , blood marker measure inflammation , patient acute coronary syndrome .</brief_summary>
	<brief_title>Targeting Inflammation Acute Coronary Syndrome Using Colchicine</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>All patient diagnosis acute coronary syndrome &gt; 18 year old contraindication colchicine . Contraindication colchicine include follow : hypersensitivity colchicine severe renal , hepatic gastrointestinal disorder blood dyscrasia ( myelodysplasia cytopenia etc ) Concurrent use moderatestrong CYP3A4 inhibitor ( complete list append full protocol ) Known severe liver disease and/or elevate transaminase &gt; 1.5x upper limit normal Estimated GFR &lt; 50 ml/min Pregnant lactate woman woman protect reliable contraception method Current treatment colchicine enrollment Active infection systemic inflammation eg active rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>